The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lantz, M., Thysell, H., Nilsson, E., & Olsson, I. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115530 · Cited by 143
RetractedInterleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationDetection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Self-citationEisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 751
Self-citationBlocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Self-citationBiological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114622 · Cited by 581
Engelmann, H., Novick, D., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40049-5 · Cited by 549
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Moldawer, L. L., Sehgal, P. B., Redington, M., Kilian, P. L., Chanock, R. M., & Prince, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1651 · Cited by 353
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α
Herbelin, A., Nguyen, A. T., Zingraff, J., Ureña, P., & Descamps-Latscha, B. (1990) · Kidney International · doi:10.1038/ki.1990.16 · Cited by 336
Nophar, Y., Kemper, O., Brakebusch, C., Englemann, H., Zwang, R., Aderka, D., Holtmann, H., & Wallach, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07526.x · Cited by 331
Purification and biologic characterization of a specific tumor necrosis factor α inhibitor
Seckinger, P., Isaaz, S., & Dayer, J. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80161-2 · Cited by 291
McIntyre, K. W., Stepan, G. J., Kolinsky, K. D., Benjamin, W. R., Plocinski, J. M., Kaffka, K. L., Campen, C. A., Chizzonite, R. A., & Kilian, P. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.931 · Cited by 289
Elevated circulating levels of interleukin-6 in patients with chronic renal failure
Herbelin, A., Ureña, P., Nguyen, A. T., Zingraff, J., & Descamps-Latscha, B. (1991) · Kidney International · doi:10.1038/ki.1991.120 · Cited by 286
Isolation and characterization of a tumor necrosis factor binding protein from urine
Olsson, I., Lantz, M., Nilsson, E., Peetre, C., Thysell, H., Grubb, A., & Adolf, G. (1989) · European Journal of Haematology · doi:10.1111/j.1600-0609.1989.tb00111.x · Cited by 245
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
Aderka, D., Englemann, H., Hornik, V., Skornick, Y. G., Levo, Y., Wallach, D., & Kushtai, G. (1991) · PubMed · Cited by 233
Spinas, G. A., Keller, U., & Brockhaus, M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115891 · Cited by 227
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
Fischer, E., Van Zee, K., Marano, M., Rock, C., Kenney, J., Poutsiaka, D., Dinarello, C., Lowry, S., & Moldawer, L. (1992) · Blood · doi:10.1182/blood.v79.9.2196.2196 · Cited by 218
Self-citationPoutsiaka, D., Clark, B., Vannier, E., & Dinarello, C. (1991) · Blood · doi:10.1182/blood.v78.5.1275.1275 · Cited by 199
Self-citationPorteu, F., Brockhaus, M., Wallach, D., Engelmann, H., & Nathan, C. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55141-3 · Cited by 187
Blood–membrane interaction in hemodialysis leads to increased cytokine production
Luger, A., Kovarik, J., Stummvoll, H., Urbanska, A., & Luger, T. A. (1987) · Kidney International · doi:10.1038/ki.1987.175 · Cited by 183
van der Meer, J. W. M., Endres, S., Lonnemann, G., Cannon, J. G., Ikejima, T., Okusawa, S., Gelfand, J. A., & Dinarello, C. A. (1988) · Journal of Leukocyte Biology · doi:10.1002/jlb.43.3.216 · Cited by 170
Self-citationEndres, S., Cannon, J. G., Ghorbani, R., Dempsey, R. A., Sisson, S. D., Lonnemann, G., Meer, J. W. M. V. D., Wolff, S. M., & Dinarello, C. A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191222 · Cited by 169
Self-citationLonnemann, G., Endres, S., Meer, J. W. M. V. D., Cannon, J. G., Koch, K. M., & Dinarello, C. A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190903 · Cited by 163
Self-citationCytokines: Agents provocateurs in hemodialysis?
Dinarello, C. A. (1992) · Kidney International · doi:10.1038/ki.1992.105 · Cited by 149
Self-citationCirculating interleukin-1β and tumor necrosis factor-α concentrations after burn injury in humans
CANNON, J. G., Friedberg, J. S., Gelfand, J. A., Tompkins, R. G., Burke, J. F., & Dinarello, C. A. (1992) · Critical Care Medicine · doi:10.1097/00003246-199210000-00009 · Cited by 141
Self-citationDinarello, C. A., Rosenwasser, L. J., & Wolff, S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2517 · Cited by 132
Self-citationCannon, J. G., van der Meer, J. W., Kwiatkowski, D. P., Endres, S., Lonnemann, G., Burke, J. F., & Dinarello, C. A. (1988) · PubMed · Cited by 122
Self-citationGene expression of interleukin-1β during hemodialysis
Schindler, R., Linnenweber, S., Schulze, M. B., Oppermann, M., Dinarello, C. A., Shaldon, S., & Km, K. (1993) · Kidney International · doi:10.1038/ki.1993.102 · Cited by 113
Self-citationMeasuring circulating cytokines
Cannon, J. G., Nerad, J. L., Poutsiaka, D. D., & Dinarello, C. A. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.4.1897 · Cited by 113
Self-citationFischer, E., Marano, M. A., Barber, A. E., Hudson, A., Lee, K., Rock, C. S., Hawes, A. S., Thompson, R. C., Hayes, T. J., Anderson, T. D., et al. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.2.r442 · Cited by 99
Plasma tumor necrosis factor soluble receptors in chronic renal failure
Brockhaus, M., Bar‐Khayim, Y., Gurwicz, S., Frensdorff, A., & Haran, N. (1992) · Kidney International · doi:10.1038/ki.1992.332 · Cited by 97
Digel, W., Porzsolt, F., Schmid, M., Herrmann, F., Lesslauer, W., & Brockhaus, M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115769 · Cited by 96
Induction of Tumor Necrosis Factor during Extracorporeal Blood Purification
Lonnemann, G., van der Meer, J. W., Cannon, J. G., Dinarello, C. A., Koch, K. M., Granolleras, C., Deschodt, G., & Shaldon, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171515 · Cited by 82
Self-citationKalinkovich, A., Engelmann, H., Harpaz, N., Burstein, R., Barak, V., Kalickman, I., Wallach, D., & Bentwich, Z. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb06961.x · Cited by 81
Shapiro, L., Clark, B. D., Orencole, S. F., Poutsiaka, D. D., Granowitz, E. V., & Dinarello, C. A. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1344 · Cited by 61
Self-citationIn vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD
Pereira, B. J. G., Poutsiaka, D. D., King, A. J., Strom, J. A., Narayan, G., Levey, A. S., & Dinarello, C. A. (1992) · Kidney International · doi:10.1038/ki.1992.436 · Cited by 58
Self-citationELISA kits based on monoclonal antibodies do not measure total IL-1β synthesis
Dinarello, C. A. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90179-w · Cited by 51
Self-citationPowell, A. C., Bland, L. E., Oettinger, C. W., et al. (1991) · Journal of the American Society of Nephrology · doi:10.1681/asn.v251007 · Cited by 40
Pereira, B. J. G., King, A. J., Poutsiaka, D. D., Strom, J. A., & Dinarello, C. A. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70320-7 · Cited by 18
Self-citation
Cited by
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T., Berglund, L., & Jogestrand, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00422.x · Cited by 1,778
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Neutrophils: Molecules, Functions and Pathophysiological Aspects
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., & Halbwachs-Mecarelli, L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780067 · Cited by 1,135
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Metadata
- Authors
- Pereira, B. J. G., Shapiro, L., King, A. J., Falagas, M. E., Strom, J. A., & Dinarello, C. A.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 1994-03
- Volume
- 45
- Issue
- 3
- Pages
- 890-896
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1983523234
- Cited by
- 384
- References
- 44
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.